Delivery Order 75A50122D00003-75A50126F61014

Award Date 9/30/26

Potential Completion Date 9/29/28

Potential Value $19M

Federal Agency

Office of the Assistant Secretary for Preparedness and Response

Awardee

Sanofi Vaccines US Inc. NCXBGGQ8YTU9

Ultimate Awardee

Not listed

NAICS Category

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

PSC Category

AN12 - Health R&D Services; Health Care Services; Applied Research

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Swiftwater, PA 18370, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The Office of the Assistant Secretary for Preparedness and Response issued a $19.4 million delivery order to Sanofi Vaccines US Inc. on September 30, 2026, for manufacture and stability studies of thimerosal-free pandemic influenza vaccine multidose vials, with completion targeted for September 29, 2028.

Place of performance is Swiftwater, PA. The order is firm fixed price with no set-aside. Sanofi Vaccines US Inc. is a division of Sanofi Pasteur Inc. and operates as a pure prime contractor with no subcontracting activity in its federal award footprint.

Generated 9/22/26, 11:44 AM